nodes	percent_of_prediction	percent_of_DWPC	metapath
Sevoflurane—ALB—chronic obstructive pulmonary disease	0.217	1	CbGaD
Sevoflurane—CYP2A6—Arformoterol—chronic obstructive pulmonary disease	0.0921	0.201	CbGbCtD
Sevoflurane—CYP2A6—Formoterol—chronic obstructive pulmonary disease	0.0921	0.201	CbGbCtD
Sevoflurane—CYP2A6—Montelukast—chronic obstructive pulmonary disease	0.0698	0.153	CbGbCtD
Sevoflurane—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.0517	0.113	CbGbCtD
Sevoflurane—CYP2A6—Prednisolone—chronic obstructive pulmonary disease	0.0409	0.0895	CbGbCtD
Sevoflurane—ALB—Prednisone—chronic obstructive pulmonary disease	0.0247	0.0539	CbGbCtD
Sevoflurane—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0243	0.0531	CbGbCtD
Sevoflurane—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0164	0.0359	CbGbCtD
Sevoflurane—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0157	0.0342	CbGbCtD
Sevoflurane—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.014	0.0305	CbGbCtD
Sevoflurane—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00819	0.0179	CbGbCtD
Sevoflurane—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00773	0.0169	CbGbCtD
Sevoflurane—ND1—respiratory system—chronic obstructive pulmonary disease	0.00138	0.0596	CbGeAlD
Sevoflurane—ATP5D—respiratory system—chronic obstructive pulmonary disease	0.00111	0.048	CbGeAlD
Sevoflurane—ND1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00111	0.048	CbGeAlD
Sevoflurane—ATP2C1—respiratory system—chronic obstructive pulmonary disease	0.0011	0.0474	CbGeAlD
Sevoflurane—GABRP—respiratory system—chronic obstructive pulmonary disease	0.00108	0.0465	CbGeAlD
Sevoflurane—ATP5D—connective tissue—chronic obstructive pulmonary disease	0.000981	0.0423	CbGeAlD
Sevoflurane—ATP5D—bronchus—chronic obstructive pulmonary disease	0.000918	0.0395	CbGeAlD
Sevoflurane—ATP2C1—bronchus—chronic obstructive pulmonary disease	0.000906	0.039	CbGeAlD
Sevoflurane—ATP5D—smooth muscle tissue—chronic obstructive pulmonary disease	0.000898	0.0387	CbGeAlD
Sevoflurane—GABRP—bronchus—chronic obstructive pulmonary disease	0.000888	0.0382	CbGeAlD
Sevoflurane—ATP2C1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000886	0.0382	CbGeAlD
Sevoflurane—GRIA1—lung—chronic obstructive pulmonary disease	0.000854	0.0368	CbGeAlD
Sevoflurane—ATP5D—trachea—chronic obstructive pulmonary disease	0.000824	0.0355	CbGeAlD
Sevoflurane—ATP2C1—trachea—chronic obstructive pulmonary disease	0.000813	0.035	CbGeAlD
Sevoflurane—GABRP—trachea—chronic obstructive pulmonary disease	0.000797	0.0343	CbGeAlD
Sevoflurane—ND1—lung—chronic obstructive pulmonary disease	0.000734	0.0316	CbGeAlD
Sevoflurane—GABRB3—respiratory system—chronic obstructive pulmonary disease	0.000698	0.0301	CbGeAlD
Sevoflurane—GABRE—bronchus—chronic obstructive pulmonary disease	0.000678	0.0292	CbGeAlD
Sevoflurane—GABRB3—connective tissue—chronic obstructive pulmonary disease	0.000614	0.0265	CbGeAlD
Sevoflurane—GABRE—trachea—chronic obstructive pulmonary disease	0.000608	0.0262	CbGeAlD
Sevoflurane—ATP5D—lung—chronic obstructive pulmonary disease	0.000592	0.0255	CbGeAlD
Sevoflurane—ATP2C1—lung—chronic obstructive pulmonary disease	0.000584	0.0252	CbGeAlD
Sevoflurane—GABRP—lung—chronic obstructive pulmonary disease	0.000573	0.0247	CbGeAlD
Sevoflurane—CYP2A6—lung—chronic obstructive pulmonary disease	0.000499	0.0215	CbGeAlD
Sevoflurane—GABRB2—lung—chronic obstructive pulmonary disease	0.000483	0.0208	CbGeAlD
Sevoflurane—CYP2B6—respiratory system—chronic obstructive pulmonary disease	0.000473	0.0204	CbGeAlD
Sevoflurane—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.000457	0.00222	CcSEcCtD
Sevoflurane—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000456	0.00222	CcSEcCtD
Sevoflurane—Urethral disorder—Salbutamol—chronic obstructive pulmonary disease	0.000456	0.00221	CcSEcCtD
Sevoflurane—Shock—Aminophylline—chronic obstructive pulmonary disease	0.000452	0.0022	CcSEcCtD
Sevoflurane—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.000452	0.0022	CcSEcCtD
Sevoflurane—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000451	0.00219	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.000449	0.00218	CcSEcCtD
Sevoflurane—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000449	0.00218	CcSEcCtD
Sevoflurane—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.000448	0.00218	CcSEcCtD
Sevoflurane—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.000445	0.00216	CcSEcCtD
Sevoflurane—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000445	0.00216	CcSEcCtD
Sevoflurane—CYP2E1—respiratory system—chronic obstructive pulmonary disease	0.000444	0.0191	CbGeAlD
Sevoflurane—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000444	0.00216	CcSEcCtD
Sevoflurane—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000444	0.00216	CcSEcCtD
Sevoflurane—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.000442	0.00215	CcSEcCtD
Sevoflurane—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.00044	0.00214	CcSEcCtD
Sevoflurane—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.00044	0.00214	CcSEcCtD
Sevoflurane—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000438	0.00213	CcSEcCtD
Sevoflurane—GABRE—lung—chronic obstructive pulmonary disease	0.000437	0.0188	CbGeAlD
Sevoflurane—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.000436	0.00212	CcSEcCtD
Sevoflurane—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000435	0.00211	CcSEcCtD
Sevoflurane—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000434	0.00211	CcSEcCtD
Sevoflurane—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000434	0.00211	CcSEcCtD
Sevoflurane—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000433	0.00211	CcSEcCtD
Sevoflurane—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000432	0.0021	CcSEcCtD
Sevoflurane—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.000431	0.0021	CcSEcCtD
Sevoflurane—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.000431	0.0021	CcSEcCtD
Sevoflurane—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.000431	0.0021	CcSEcCtD
Sevoflurane—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000429	0.00209	CcSEcCtD
Sevoflurane—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.000429	0.00208	CcSEcCtD
Sevoflurane—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.000429	0.00208	CcSEcCtD
Sevoflurane—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000426	0.00207	CcSEcCtD
Sevoflurane—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000425	0.00207	CcSEcCtD
Sevoflurane—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000423	0.00206	CcSEcCtD
Sevoflurane—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.000422	0.00205	CcSEcCtD
Sevoflurane—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.000422	0.00205	CcSEcCtD
Sevoflurane—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000421	0.00205	CcSEcCtD
Sevoflurane—Tension—Formoterol—chronic obstructive pulmonary disease	0.000421	0.00204	CcSEcCtD
Sevoflurane—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000421	0.00204	CcSEcCtD
Sevoflurane—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00042	0.00204	CcSEcCtD
Sevoflurane—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.00042	0.00204	CcSEcCtD
Sevoflurane—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.00042	0.00204	CcSEcCtD
Sevoflurane—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000419	0.00204	CcSEcCtD
Sevoflurane—Chills—Salbutamol—chronic obstructive pulmonary disease	0.000417	0.00203	CcSEcCtD
Sevoflurane—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000416	0.00202	CcSEcCtD
Sevoflurane—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000416	0.00202	CcSEcCtD
Sevoflurane—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000416	0.00202	CcSEcCtD
Sevoflurane—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.000415	0.00202	CcSEcCtD
Sevoflurane—Leukocytosis—Prednisone—chronic obstructive pulmonary disease	0.000411	0.002	CcSEcCtD
Sevoflurane—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000409	0.00199	CcSEcCtD
Sevoflurane—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000407	0.00198	CcSEcCtD
Sevoflurane—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000405	0.00197	CcSEcCtD
Sevoflurane—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.000398	0.00194	CcSEcCtD
Sevoflurane—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000397	0.00193	CcSEcCtD
Sevoflurane—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000396	0.00193	CcSEcCtD
Sevoflurane—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000394	0.00191	CcSEcCtD
Sevoflurane—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000394	0.00191	CcSEcCtD
Sevoflurane—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000393	0.00191	CcSEcCtD
Sevoflurane—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000392	0.00191	CcSEcCtD
Sevoflurane—CYP2B6—bronchus—chronic obstructive pulmonary disease	0.000389	0.0168	CbGeAlD
Sevoflurane—Hiccups—Prednisone—chronic obstructive pulmonary disease	0.000386	0.00188	CcSEcCtD
Sevoflurane—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000386	0.00188	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000374	0.00182	CcSEcCtD
Sevoflurane—Cough—Formoterol—chronic obstructive pulmonary disease	0.000374	0.00182	CcSEcCtD
Sevoflurane—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000374	0.00182	CcSEcCtD
Sevoflurane—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000372	0.00181	CcSEcCtD
Sevoflurane—GABRB3—lung—chronic obstructive pulmonary disease	0.000371	0.016	CbGeAlD
Sevoflurane—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00037	0.0018	CcSEcCtD
Sevoflurane—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00037	0.0018	CcSEcCtD
Sevoflurane—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.000366	0.00178	CcSEcCtD
Sevoflurane—Cough—Montelukast—chronic obstructive pulmonary disease	0.000366	0.00178	CcSEcCtD
Sevoflurane—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000365	0.00177	CcSEcCtD
Sevoflurane—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000365	0.00177	CcSEcCtD
Sevoflurane—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000365	0.00177	CcSEcCtD
Sevoflurane—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000364	0.00177	CcSEcCtD
Sevoflurane—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000363	0.00177	CcSEcCtD
Sevoflurane—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000363	0.00176	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000362	0.00176	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000362	0.00176	CcSEcCtD
Sevoflurane—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000357	0.00173	CcSEcCtD
Sevoflurane—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000357	0.00173	CcSEcCtD
Sevoflurane—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000356	0.00173	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000355	0.00173	CcSEcCtD
Sevoflurane—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000353	0.00172	CcSEcCtD
Sevoflurane—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00035	0.0017	CcSEcCtD
Sevoflurane—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00035	0.0017	CcSEcCtD
Sevoflurane—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00035	0.0017	CcSEcCtD
Sevoflurane—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00035	0.0017	CcSEcCtD
Sevoflurane—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000349	0.0017	CcSEcCtD
Sevoflurane—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000344	0.00167	CcSEcCtD
Sevoflurane—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000344	0.00167	CcSEcCtD
Sevoflurane—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000343	0.00167	CcSEcCtD
Sevoflurane—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000343	0.00167	CcSEcCtD
Sevoflurane—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000343	0.00167	CcSEcCtD
Sevoflurane—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000343	0.00167	CcSEcCtD
Sevoflurane—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000341	0.00166	CcSEcCtD
Sevoflurane—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000341	0.00166	CcSEcCtD
Sevoflurane—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00034	0.00165	CcSEcCtD
Sevoflurane—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00034	0.00165	CcSEcCtD
Sevoflurane—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000339	0.00165	CcSEcCtD
Sevoflurane—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000337	0.00164	CcSEcCtD
Sevoflurane—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000336	0.00163	CcSEcCtD
Sevoflurane—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000335	0.00163	CcSEcCtD
Sevoflurane—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000333	0.00162	CcSEcCtD
Sevoflurane—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00033	0.00161	CcSEcCtD
Sevoflurane—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00033	0.00161	CcSEcCtD
Sevoflurane—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000327	0.00159	CcSEcCtD
Sevoflurane—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000327	0.00159	CcSEcCtD
Sevoflurane—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000327	0.00159	CcSEcCtD
Sevoflurane—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000325	0.00158	CcSEcCtD
Sevoflurane—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000325	0.00158	CcSEcCtD
Sevoflurane—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000324	0.00157	CcSEcCtD
Sevoflurane—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000322	0.00157	CcSEcCtD
Sevoflurane—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000321	0.00156	CcSEcCtD
Sevoflurane—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000319	0.00155	CcSEcCtD
Sevoflurane—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000316	0.00154	CcSEcCtD
Sevoflurane—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000316	0.00154	CcSEcCtD
Sevoflurane—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000312	0.00152	CcSEcCtD
Sevoflurane—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000312	0.00152	CcSEcCtD
Sevoflurane—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000311	0.00151	CcSEcCtD
Sevoflurane—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000311	0.00151	CcSEcCtD
Sevoflurane—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00031	0.00151	CcSEcCtD
Sevoflurane—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000309	0.0015	CcSEcCtD
Sevoflurane—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000307	0.00149	CcSEcCtD
Sevoflurane—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000305	0.00148	CcSEcCtD
Sevoflurane—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000304	0.00148	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000302	0.00147	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000302	0.00147	CcSEcCtD
Sevoflurane—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000299	0.00145	CcSEcCtD
Sevoflurane—Pain—Formoterol—chronic obstructive pulmonary disease	0.000299	0.00145	CcSEcCtD
Sevoflurane—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000299	0.00145	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000296	0.00144	CcSEcCtD
Sevoflurane—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000294	0.00143	CcSEcCtD
Sevoflurane—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000294	0.00143	CcSEcCtD
Sevoflurane—Pain—Montelukast—chronic obstructive pulmonary disease	0.000293	0.00142	CcSEcCtD
Sevoflurane—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000292	0.00142	CcSEcCtD
Sevoflurane—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00029	0.00141	CcSEcCtD
Sevoflurane—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000289	0.00141	CcSEcCtD
Sevoflurane—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000289	0.0014	CcSEcCtD
Sevoflurane—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000288	0.0014	CcSEcCtD
Sevoflurane—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000288	0.0014	CcSEcCtD
Sevoflurane—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000288	0.0014	CcSEcCtD
Sevoflurane—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000287	0.00139	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000285	0.00139	CcSEcCtD
Sevoflurane—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000282	0.00137	CcSEcCtD
Sevoflurane—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000278	0.00135	CcSEcCtD
Sevoflurane—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000278	0.00135	CcSEcCtD
Sevoflurane—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000276	0.00134	CcSEcCtD
Sevoflurane—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000276	0.00134	CcSEcCtD
Sevoflurane—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000276	0.00134	CcSEcCtD
Sevoflurane—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000273	0.00133	CcSEcCtD
Sevoflurane—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000273	0.00133	CcSEcCtD
Sevoflurane—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000273	0.00133	CcSEcCtD
Sevoflurane—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000272	0.00132	CcSEcCtD
Sevoflurane—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000272	0.00132	CcSEcCtD
Sevoflurane—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000271	0.00132	CcSEcCtD
Sevoflurane—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000271	0.00132	CcSEcCtD
Sevoflurane—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000271	0.00132	CcSEcCtD
Sevoflurane—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000268	0.0013	CcSEcCtD
Sevoflurane—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000267	0.0013	CcSEcCtD
Sevoflurane—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000266	0.00129	CcSEcCtD
Sevoflurane—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000262	0.00128	CcSEcCtD
Sevoflurane—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000261	0.00127	CcSEcCtD
Sevoflurane—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000258	0.00125	CcSEcCtD
Sevoflurane—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000258	0.00125	CcSEcCtD
Sevoflurane—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000257	0.00125	CcSEcCtD
Sevoflurane—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000252	0.00123	CcSEcCtD
Sevoflurane—CYP2B6—lung—chronic obstructive pulmonary disease	0.000251	0.0108	CbGeAlD
Sevoflurane—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000251	0.00122	CcSEcCtD
Sevoflurane—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000251	0.00122	CcSEcCtD
Sevoflurane—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000247	0.0012	CcSEcCtD
Sevoflurane—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000247	0.0012	CcSEcCtD
Sevoflurane—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000246	0.00119	CcSEcCtD
Sevoflurane—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000243	0.00118	CcSEcCtD
Sevoflurane—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000242	0.00118	CcSEcCtD
Sevoflurane—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000238	0.00116	CcSEcCtD
Sevoflurane—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000237	0.00115	CcSEcCtD
Sevoflurane—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000237	0.00115	CcSEcCtD
Sevoflurane—CYP2E1—lung—chronic obstructive pulmonary disease	0.000236	0.0102	CbGeAlD
Sevoflurane—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000234	0.00114	CcSEcCtD
Sevoflurane—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000231	0.00112	CcSEcCtD
Sevoflurane—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000231	0.00112	CcSEcCtD
Sevoflurane—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000227	0.0011	CcSEcCtD
Sevoflurane—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000222	0.00108	CcSEcCtD
Sevoflurane—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000222	0.00108	CcSEcCtD
Sevoflurane—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000221	0.00107	CcSEcCtD
Sevoflurane—Rash—Formoterol—chronic obstructive pulmonary disease	0.000221	0.00107	CcSEcCtD
Sevoflurane—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00022	0.00107	CcSEcCtD
Sevoflurane—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00022	0.00107	CcSEcCtD
Sevoflurane—Headache—Formoterol—chronic obstructive pulmonary disease	0.000219	0.00107	CcSEcCtD
Sevoflurane—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000219	0.00107	CcSEcCtD
Sevoflurane—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000218	0.00106	CcSEcCtD
Sevoflurane—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000218	0.00106	CcSEcCtD
Sevoflurane—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000218	0.00106	CcSEcCtD
Sevoflurane—Rash—Montelukast—chronic obstructive pulmonary disease	0.000216	0.00105	CcSEcCtD
Sevoflurane—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000216	0.00105	CcSEcCtD
Sevoflurane—Headache—Montelukast—chronic obstructive pulmonary disease	0.000215	0.00104	CcSEcCtD
Sevoflurane—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00021	0.00102	CcSEcCtD
Sevoflurane—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000208	0.00101	CcSEcCtD
Sevoflurane—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000208	0.00101	CcSEcCtD
Sevoflurane—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000208	0.00101	CcSEcCtD
Sevoflurane—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000208	0.00101	CcSEcCtD
Sevoflurane—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000208	0.00101	CcSEcCtD
Sevoflurane—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000207	0.00101	CcSEcCtD
Sevoflurane—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000204	0.000992	CcSEcCtD
Sevoflurane—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000203	0.000989	CcSEcCtD
Sevoflurane—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000201	0.000977	CcSEcCtD
Sevoflurane—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.0002	0.000974	CcSEcCtD
Sevoflurane—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000197	0.000959	CcSEcCtD
Sevoflurane—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000196	0.000954	CcSEcCtD
Sevoflurane—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000195	0.000947	CcSEcCtD
Sevoflurane—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000194	0.000942	CcSEcCtD
Sevoflurane—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000189	0.000921	CcSEcCtD
Sevoflurane—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000189	0.000921	CcSEcCtD
Sevoflurane—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000186	0.000906	CcSEcCtD
Sevoflurane—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000185	0.000899	CcSEcCtD
Sevoflurane—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000176	0.000854	CcSEcCtD
Sevoflurane—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000175	0.000851	CcSEcCtD
Sevoflurane—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000173	0.000841	CcSEcCtD
Sevoflurane—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000171	0.000833	CcSEcCtD
Sevoflurane—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.00017	0.000825	CcSEcCtD
Sevoflurane—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000169	0.00082	CcSEcCtD
Sevoflurane—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000162	0.000787	CcSEcCtD
Sevoflurane—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000156	0.000759	CcSEcCtD
Sevoflurane—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000155	0.000753	CcSEcCtD
Sevoflurane—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000151	0.000735	CcSEcCtD
Sevoflurane—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.00015	0.000731	CcSEcCtD
Sevoflurane—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000148	0.000721	CcSEcCtD
Sevoflurane—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000146	0.00071	CcSEcCtD
Sevoflurane—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000146	0.000708	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000143	0.000693	CcSEcCtD
Sevoflurane—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00014	0.000678	CcSEcCtD
Sevoflurane—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000138	0.000669	CcSEcCtD
Sevoflurane—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000138	0.000669	CcSEcCtD
Sevoflurane—Shock—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000658	CcSEcCtD
Sevoflurane—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000656	CcSEcCtD
Sevoflurane—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000134	0.000653	CcSEcCtD
Sevoflurane—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000134	0.00065	CcSEcCtD
Sevoflurane—GABRA5—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00013	0.00134	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000128	0.00132	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000128	0.00132	CbGpPWpGaD
Sevoflurane—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000128	0.00131	CbGpPWpGaD
Sevoflurane—GABRA3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000127	0.00131	CbGpPWpGaD
Sevoflurane—ALB—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.000127	0.00131	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000126	0.0013	CbGpPWpGaD
Sevoflurane—ALB—Platelet degranulation—TGFB2—chronic obstructive pulmonary disease	0.000126	0.0013	CbGpPWpGaD
Sevoflurane—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000125	0.000609	CcSEcCtD
Sevoflurane—GABRA2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000125	0.00129	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—GC—chronic obstructive pulmonary disease	0.000125	0.00129	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—GC—chronic obstructive pulmonary disease	0.000125	0.00129	CbGpPWpGaD
Sevoflurane—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000124	0.000605	CcSEcCtD
Sevoflurane—GABRB3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000124	0.00128	CbGpPWpGaD
Sevoflurane—GABRG2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000122	0.00126	CbGpPWpGaD
Sevoflurane—CYP2A6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000122	0.00125	CbGpPWpGaD
Sevoflurane—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000121	0.00125	CbGpPWpGaD
Sevoflurane—CYP2A6—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.000121	0.00124	CbGpPWpGaD
Sevoflurane—ALB—Response to elevated platelet cytosolic Ca2+—TGFB2—chronic obstructive pulmonary disease	0.00012	0.00123	CbGpPWpGaD
Sevoflurane—CYP2B6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.00012	0.00123	CbGpPWpGaD
Sevoflurane—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000119	0.000581	CcSEcCtD
Sevoflurane—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000119	0.00123	CbGpPWpGaD
Sevoflurane—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000119	0.00058	CcSEcCtD
Sevoflurane—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000119	0.00122	CbGpPWpGaD
Sevoflurane—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000119	0.000577	CcSEcCtD
Sevoflurane—CYP2E1—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000117	0.00121	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000116	0.0012	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000116	0.0012	CbGpPWpGaD
Sevoflurane—CYP2A6—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.000114	0.00118	CbGpPWpGaD
Sevoflurane—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000113	0.000551	CcSEcCtD
Sevoflurane—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000113	0.000547	CcSEcCtD
Sevoflurane—CYP2A6—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.000112	0.00116	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—RAPGEF3—chronic obstructive pulmonary disease	0.000112	0.00115	CbGpPWpGaD
Sevoflurane—GLRA1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000112	0.00115	CbGpPWpGaD
Sevoflurane—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000532	CcSEcCtD
Sevoflurane—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000529	CcSEcCtD
Sevoflurane—CYP2A6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000107	0.0011	CbGpPWpGaD
Sevoflurane—GABRA1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000107	0.0011	CbGpPWpGaD
Sevoflurane—CYP2A6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000106	0.00109	CbGpPWpGaD
Sevoflurane—ALB—Vitamin B12 Metabolism—CRP—chronic obstructive pulmonary disease	0.000103	0.00106	CbGpPWpGaD
Sevoflurane—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000493	CcSEcCtD
Sevoflurane—Asthenia—Prednisone—chronic obstructive pulmonary disease	9.88e-05	0.00048	CcSEcCtD
Sevoflurane—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	9.82e-05	0.00101	CbGpPWpGaD
Sevoflurane—Pruritus—Prednisone—chronic obstructive pulmonary disease	9.74e-05	0.000473	CcSEcCtD
Sevoflurane—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	9.62e-05	0.000992	CbGpPWpGaD
Sevoflurane—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	9.37e-05	0.000966	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	9.26e-05	0.000954	CbGpPWpGaD
Sevoflurane—Dizziness—Prednisone—chronic obstructive pulmonary disease	9.1e-05	0.000442	CcSEcCtD
Sevoflurane—CYP2A6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.9e-05	0.000917	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	8.75e-05	0.000902	CbGpPWpGaD
Sevoflurane—Vomiting—Prednisone—chronic obstructive pulmonary disease	8.75e-05	0.000425	CcSEcCtD
Sevoflurane—Rash—Prednisone—chronic obstructive pulmonary disease	8.68e-05	0.000422	CcSEcCtD
Sevoflurane—Dermatitis—Prednisone—chronic obstructive pulmonary disease	8.67e-05	0.000421	CcSEcCtD
Sevoflurane—CYP2B6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.64e-05	0.000891	CbGpPWpGaD
Sevoflurane—Headache—Prednisone—chronic obstructive pulmonary disease	8.62e-05	0.000419	CcSEcCtD
Sevoflurane—CYP2A6—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	8.58e-05	0.000884	CbGpPWpGaD
Sevoflurane—CYP2B6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8.54e-05	0.00088	CbGpPWpGaD
Sevoflurane—CYP2E1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.46e-05	0.000872	CbGpPWpGaD
Sevoflurane—CYP2A6—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	8.46e-05	0.000872	CbGpPWpGaD
Sevoflurane—ALB—Folate Metabolism—CRP—chronic obstructive pulmonary disease	8.38e-05	0.000864	CbGpPWpGaD
Sevoflurane—CYP2E1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8.37e-05	0.000862	CbGpPWpGaD
Sevoflurane—CYP2A6—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	8.35e-05	0.00086	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	8.25e-05	0.00085	CbGpPWpGaD
Sevoflurane—Nausea—Prednisone—chronic obstructive pulmonary disease	8.18e-05	0.000397	CcSEcCtD
Sevoflurane—ALB—Vitamin B12 Metabolism—SERPINE1—chronic obstructive pulmonary disease	7.91e-05	0.000815	CbGpPWpGaD
Sevoflurane—ATP2C1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	7.9e-05	0.000814	CbGpPWpGaD
Sevoflurane—CYP2A6—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	7.78e-05	0.000802	CbGpPWpGaD
Sevoflurane—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	7.75e-05	0.000799	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	7.75e-05	0.000798	CbGpPWpGaD
Sevoflurane—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	7.58e-05	0.000781	CbGpPWpGaD
Sevoflurane—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	7.48e-05	0.000771	CbGpPWpGaD
Sevoflurane—CYP2A6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.42e-05	0.000765	CbGpPWpGaD
Sevoflurane—CYP2B6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.18e-05	0.00074	CbGpPWpGaD
Sevoflurane—CYP2B6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.08e-05	0.00073	CbGpPWpGaD
Sevoflurane—CYP2E1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.03e-05	0.000725	CbGpPWpGaD
Sevoflurane—CYP2E1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.94e-05	0.000715	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.83e-05	0.000704	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.83e-05	0.000704	CbGpPWpGaD
Sevoflurane—CYP2A6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.82e-05	0.000703	CbGpPWpGaD
Sevoflurane—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	6.81e-05	0.000702	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—GCLC—chronic obstructive pulmonary disease	6.75e-05	0.000696	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—GCLC—chronic obstructive pulmonary disease	6.75e-05	0.000696	CbGpPWpGaD
Sevoflurane—GLRA1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.71e-05	0.000692	CbGpPWpGaD
Sevoflurane—ALB—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	6.66e-05	0.000686	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	6.61e-05	0.000681	CbGpPWpGaD
Sevoflurane—CYP2A6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.47e-05	0.000667	CbGpPWpGaD
Sevoflurane—ALB—Folate Metabolism—SERPINE1—chronic obstructive pulmonary disease	6.44e-05	0.000663	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	6.43e-05	0.000663	CbGpPWpGaD
Sevoflurane—ALB—Vitamin B12 Metabolism—IL1B—chronic obstructive pulmonary disease	6.43e-05	0.000662	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—CTGF—chronic obstructive pulmonary disease	6.16e-05	0.000635	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—CTGF—chronic obstructive pulmonary disease	6.16e-05	0.000635	CbGpPWpGaD
Sevoflurane—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	6.14e-05	0.000633	CbGpPWpGaD
Sevoflurane—CYP2B6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.99e-05	0.000617	CbGpPWpGaD
Sevoflurane—CYP2B6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.91e-05	0.000609	CbGpPWpGaD
Sevoflurane—CYP2E1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.87e-05	0.000605	CbGpPWpGaD
Sevoflurane—CYP2E1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.79e-05	0.000596	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	5.77e-05	0.000595	CbGpPWpGaD
Sevoflurane—GABRQ—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.72e-05	0.00059	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.67e-05	0.000585	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.67e-05	0.000585	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	5.58e-05	0.000575	CbGpPWpGaD
Sevoflurane—ALB—Platelet degranulation—SERPINE1—chronic obstructive pulmonary disease	5.52e-05	0.000569	CbGpPWpGaD
Sevoflurane—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	5.51e-05	0.000568	CbGpPWpGaD
Sevoflurane—CYP2B6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.5e-05	0.000567	CbGpPWpGaD
Sevoflurane—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	5.43e-05	0.00056	CbGpPWpGaD
Sevoflurane—CYP2B6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.43e-05	0.00056	CbGpPWpGaD
Sevoflurane—CYP2E1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.39e-05	0.000556	CbGpPWpGaD
Sevoflurane—CYP2E1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.32e-05	0.000548	CbGpPWpGaD
Sevoflurane—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—chronic obstructive pulmonary disease	5.26e-05	0.000542	CbGpPWpGaD
Sevoflurane—ALB—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	5.23e-05	0.000539	CbGpPWpGaD
Sevoflurane—CYP2B6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.22e-05	0.000538	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—APIP—chronic obstructive pulmonary disease	5.2e-05	0.000536	CbGpPWpGaD
Sevoflurane—CYP2B6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.15e-05	0.00053	CbGpPWpGaD
Sevoflurane—ALB—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	5.11e-05	0.000527	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	5.11e-05	0.000527	CbGpPWpGaD
Sevoflurane—CYP2E1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.11e-05	0.000527	CbGpPWpGaD
Sevoflurane—CYP2E1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.04e-05	0.00052	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	4.79e-05	0.000493	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.73e-05	0.000488	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.73e-05	0.000488	CbGpPWpGaD
Sevoflurane—GABRG3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.71e-05	0.000486	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.67e-05	0.000481	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.67e-05	0.000481	CbGpPWpGaD
Sevoflurane—ALB—Vitamin B12 Metabolism—TNF—chronic obstructive pulmonary disease	4.66e-05	0.000481	CbGpPWpGaD
Sevoflurane—GABRB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.64e-05	0.000479	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	4.59e-05	0.000473	CbGpPWpGaD
Sevoflurane—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	4.46e-05	0.00046	CbGpPWpGaD
Sevoflurane—GABRA6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.39e-05	0.000453	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.35e-05	0.000448	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.35e-05	0.000448	CbGpPWpGaD
Sevoflurane—GABRA4—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.34e-05	0.000447	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—APIP—chronic obstructive pulmonary disease	4.2e-05	0.000433	CbGpPWpGaD
Sevoflurane—ALB—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	4.15e-05	0.000428	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.12e-05	0.000425	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.12e-05	0.000425	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—APIP—chronic obstructive pulmonary disease	4.11e-05	0.000424	CbGpPWpGaD
Sevoflurane—GABRB2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.97e-05	0.000409	CbGpPWpGaD
Sevoflurane—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	3.93e-05	0.000405	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	3.89e-05	0.000401	CbGpPWpGaD
Sevoflurane—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.88e-05	0.0004	CbGpPWpGaD
Sevoflurane—GABRA5—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.85e-05	0.000397	CbGpPWpGaD
Sevoflurane—ALB—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	3.8e-05	0.000391	CbGpPWpGaD
Sevoflurane—ALB—Folate Metabolism—TNF—chronic obstructive pulmonary disease	3.79e-05	0.000391	CbGpPWpGaD
Sevoflurane—GABRA3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.78e-05	0.00039	CbGpPWpGaD
Sevoflurane—ALB—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	3.76e-05	0.000388	CbGpPWpGaD
Sevoflurane—GABRA2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.72e-05	0.000383	CbGpPWpGaD
Sevoflurane—GABRB3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.7e-05	0.000381	CbGpPWpGaD
Sevoflurane—GABRG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.63e-05	0.000374	CbGpPWpGaD
Sevoflurane—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	3.62e-05	0.000373	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—APIP—chronic obstructive pulmonary disease	3.53e-05	0.000364	CbGpPWpGaD
Sevoflurane—ALB—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	3.48e-05	0.000359	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.45e-05	0.000355	CbGpPWpGaD
Sevoflurane—GABRQ—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.44e-05	0.000354	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—GC—chronic obstructive pulmonary disease	3.35e-05	0.000346	CbGpPWpGaD
Sevoflurane—ALB—Folate Metabolism—TP53—chronic obstructive pulmonary disease	3.35e-05	0.000345	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	3.33e-05	0.000343	CbGpPWpGaD
Sevoflurane—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	3.32e-05	0.000342	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	3.32e-05	0.000342	CbGpPWpGaD
Sevoflurane—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.26e-05	0.000336	CbGpPWpGaD
Sevoflurane—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.22e-05	0.000332	CbGpPWpGaD
Sevoflurane—GABRA1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.17e-05	0.000327	CbGpPWpGaD
Sevoflurane—CYP2A6—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	3.17e-05	0.000327	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.12e-05	0.000321	CbGpPWpGaD
Sevoflurane—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	3.06e-05	0.000316	CbGpPWpGaD
Sevoflurane—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	3.01e-05	0.000311	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	2.88e-05	0.000296	CbGpPWpGaD
Sevoflurane—GABRG3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.83e-05	0.000292	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—ALB—chronic obstructive pulmonary disease	2.8e-05	0.000289	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—ALB—chronic obstructive pulmonary disease	2.8e-05	0.000289	CbGpPWpGaD
Sevoflurane—GABRB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.79e-05	0.000287	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.78e-05	0.000287	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.72e-05	0.000281	CbGpPWpGaD
Sevoflurane—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.72e-05	0.000281	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GC—chronic obstructive pulmonary disease	2.71e-05	0.000279	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	2.69e-05	0.000277	CbGpPWpGaD
Sevoflurane—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.68e-05	0.000277	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—NOS3—chronic obstructive pulmonary disease	2.68e-05	0.000276	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.68e-05	0.000276	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GC—chronic obstructive pulmonary disease	2.65e-05	0.000273	CbGpPWpGaD
Sevoflurane—GABRA6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.64e-05	0.000272	CbGpPWpGaD
Sevoflurane—GABRA4—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.6e-05	0.000268	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	2.58e-05	0.000266	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.52e-05	0.00026	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.51e-05	0.000259	CbGpPWpGaD
Sevoflurane—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.5e-05	0.000258	CbGpPWpGaD
Sevoflurane—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.47e-05	0.000254	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.46e-05	0.000254	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	2.45e-05	0.000252	CbGpPWpGaD
Sevoflurane—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	2.43e-05	0.000251	CbGpPWpGaD
Sevoflurane—GABRB2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.38e-05	0.000246	CbGpPWpGaD
Sevoflurane—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.37e-05	0.000244	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.34e-05	0.000241	CbGpPWpGaD
Sevoflurane—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.34e-05	0.000241	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	2.33e-05	0.00024	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.32e-05	0.000239	CbGpPWpGaD
Sevoflurane—GABRA5—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.31e-05	0.000239	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GC—chronic obstructive pulmonary disease	2.28e-05	0.000235	CbGpPWpGaD
Sevoflurane—GABRA3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.27e-05	0.000234	CbGpPWpGaD
Sevoflurane—GABRA2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.23e-05	0.00023	CbGpPWpGaD
Sevoflurane—GABRB3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.22e-05	0.000229	CbGpPWpGaD
Sevoflurane—GABRG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.18e-05	0.000225	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.12e-05	0.000218	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.91e-05	0.000197	CbGpPWpGaD
Sevoflurane—GABRA1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.9e-05	0.000196	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.83e-05	0.000189	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.82e-05	0.000187	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.81e-05	0.000187	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.69e-05	0.000174	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	1.68e-05	0.000174	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	1.66e-05	0.000171	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.65e-05	0.00017	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	1.63e-05	0.000168	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	1.55e-05	0.000159	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.52e-05	0.000157	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	1.5e-05	0.000154	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.48e-05	0.000152	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.46e-05	0.000151	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.45e-05	0.000149	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.43e-05	0.000147	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.33e-05	0.000137	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.31e-05	0.000135	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.27e-05	0.000131	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.26e-05	0.00013	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	1.26e-05	0.00013	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.25e-05	0.000129	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.24e-05	0.000128	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	1.23e-05	0.000127	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.23e-05	0.000127	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.23e-05	0.000127	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	1.2e-05	0.000124	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.2e-05	0.000124	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.17e-05	0.00012	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.14e-05	0.000118	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	1.12e-05	0.000116	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.11e-05	0.000114	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.03e-05	0.000107	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.02e-05	0.000106	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.01e-05	0.000104	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1e-05	0.000103	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.89e-06	0.000102	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.41e-06	9.7e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.22e-06	9.5e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.92e-06	9.2e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.74e-06	9.01e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	8.68e-06	8.95e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.62e-06	8.89e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.5e-06	8.77e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	7.97e-06	8.21e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.92e-06	8.17e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—ALB—chronic obstructive pulmonary disease	7.52e-06	7.75e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.51e-06	7.74e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—NOS3—chronic obstructive pulmonary disease	7.19e-06	7.41e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.72e-06	6.92e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	6.64e-06	6.84e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	6.56e-06	6.76e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	6.07e-06	6.25e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	6.06e-06	6.24e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	5.94e-06	6.12e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	5.8e-06	5.98e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	5.68e-06	5.86e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.58e-06	5.75e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	4.88e-06	5.03e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.65e-06	4.8e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.59e-06	4.73e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.28e-06	4.41e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.05e-06	4.18e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.76e-06	2.84e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.64e-06	2.72e-05	CbGpPWpGaD
